Inovio Pharmaceuticals - Public

1787 Sentry Parkway West
Blue Bell, PA 19422 USA
Phone
Fax
Click for website

Research Sector Pharmaceutical

Summary Description DNA vaccines to prevent and treat cancers and infectious diseases

Management J. Joseph Kim, Ph.D., Chief Executive Officer; Peter Kies, Chief Financial Officer; Mark L. Bagarazzi, Chief Medical Officer; Niranjan Y. Sardesai, Ph.D., Chief Operating Officer

Click here for Financial Data
Keywords: immunotherapies, pharmaceutical, DNA vaccines, influenza

Comment


Updated: Sept. 22, 2014


Description

Inovio is revolutionizing vaccines to prevent and treat today's cancers and challenging infectious diseases. Its SynCon® vaccines are designed to help the immune system identify and fight cancer cell......view more

Products / Services

Inovio is targeting cancers and infectious diseases with preventive and/or therapeutic vaccines. We currently have preventive and/or therapeutic DNA vaccines for HPV-associated diseases including dysp......view more

Technology / Differentiation

Inovios DNA vaccines are made of DNA plasmids encoded to produce one or more antigens associated with a target infectious disease or cancer. Being synthetic, they are not made using a live-attenuated...view more

Market / Customers

Inovio is targeting cancers and infectious diseases with preventive and/or therapeutic vaccines......view more


Strategy

-...view more

Status

Inovio is currently advancing multiple phase I and II clinical trials. Its lead program is a therapeutic DNA vaccine targeting HPV-associated diseases. An ongoing phase II study for advanced cervical ...view more

RELATED COMPANIES



    0000-00-00-9796